As of 2024-12-14, the Fair Value of Vertex Pharmaceuticals Inc (VRTX) is -46.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 463.73 USD, the upside of Vertex Pharmaceuticals Inc is -109.94%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 1,176.80 | 2,711.60 | 2,342.10 | 3,322.00 | 3,619.60 | 2,634.42 |
| YoY growth | -43.88% | 130.42% | -13.63% | 41.84% | 8.96% | 24.74% |
| Market Cap (mil) | 119,424.39 |
| P/E | |
| Forward P/E | 28.80x |
| EPS | -1.86 |
| Avg earnings growth rate | 24.74% |
| TTM earnings | -479.80 |